جست‌وجوی استاد و پژوهشگر

• Emergency Medicine
• Pediatric Emergencies
• Medical Education
• +۳ مورد دیگر

Dr. Emily Rose is an Associate Professor of Clinical Emergency Medicine and Director of Pre-Health Undergraduate Studies at the Keck School of Medicine of the University of Southern California. She is also Director of the Minor in Health Care Studies. With over a decade of clinical experience, she specializes in pediatric and adult emergency care, emphasizing innovative medical education and professionalism. Dr. Rose holds leadership roles in residency training and undergraduate medical education, alongside national speaking engagements on pediatric emergencies and emergency medicine pedagogy. Education & Training : Emergency Medicine Residency, Los Angeles County/USC Medical Center (Chief Resident 2007-2008) Pediatric Emergency Medicine Fellowship, Loma Linda University Research Interests : Dr. Rose focuses on pediatric emergency care, medical education strategies, and improving patient outcomes through standardized training. She has authored a textbook on life-threatening rashes and is developing a practical guide for pediatric emergencies. Her work emphasizes evidence-based practices in pain management, dehydration, and critical care. Recent Contributions : Her articles address opioid crisis management in children, pediatric stroke protocols, and non-pharmacological pain relief. She advocates for interdisciplinary approaches to behavioral health emergencies and innovative teaching methods like flipped classrooms. Awards : Outstanding Teaching Performance Award (2017-2018) ACEP Honorable Mention Outstanding Speaker (2016-2017) Emergency Medicine Residency Faculty of the Year (2013-2014) Advancing Practice : Dr. Rose leads workshops on pediatric resuscitation, airway management, and procedural sedation. She collaborates with institutions nationwide to standardize emergency care protocols and improve pre-health education pathways. Labs & Teams : Active in the Emergency Medicine Residency Program and Keck School's educational initiatives, she contributes to simulation-based training and curriculum development for medical students and residents.

• Pediatric Endocrinology
• Genetic Disorders
• Metabolic Disorders
• +۳ مورد دیگر

Anna Ryabets-Lienhard, DO, is an Assistant Professor of Clinical Pediatrics at the University of Southern California, affiliated with Children's Hospital Los Angeles (CHLA). Her clinical and research focus centers on pediatric endocrinology, with particular expertise in genetic disorders, metabolic syndromes, and rare pediatric conditions. She actively contributes to translational and clinical studies addressing skeletal abnormalities, hormonal dysregulation, and pharmacotherapeutic strategies for complex pediatric cases. Dr. Ryabets-Lienhard's research interests span genetic mutations affecting bone metabolism (e.g., GNAS, FAM111B), metabolic complications in Duchenne muscular dystrophy, and endocrine manifestations of syndromic disorders like congenital adrenal hyperplasia. Her work emphasizes improving clinical outcomes through biomarker identification and guideline development for therapies such as Teplizumab. Her publications reflect a multidisciplinary approach, integrating genetics, endocrinology, and clinical care. Notable contributions include studies on pseudohypoparathyroidism epigenetics, RANKL/OPG ratios in muscular dystrophies, and carotid intima-media thickness in congenital adrenal hyperplasia patients. She regularly participates in national meetings, including the Pediatric Endocrine Society and Endocrine Society conferences, to disseminate findings and shape clinical practice. Dr. Ryabets-Lienhard’s clinical expertise includes managing complex cases such as optic nerve hypoplasia, progressive osseous heteroplasia, and syndromic skeletal disorders. She collaborates with CHLA and USC teams to advance care for pediatric patients with rare and multifaceted endocrine conditions.

• Medical Oncology
• Cancer Research
• Molecular Profiling
• +۳ مورد دیگر

Jacob Stephen Thomas is an Assistant Professor of Clinical Medicine at the University of Southern California (USC) and serves as the Service Chief of LAC+USC Oncology. His clinical and research work focuses on oncology, including targeted therapies, cancer epidemiology, and molecular profiling. He practices at a major academic medical institution in Los Angeles, where he contributes to clinical care and translational research. His research spans multiple cancer subfields, including non-small cell lung cancer, melanoma, and head and neck cancers. He investigates biomarkers like platelet-lymphocyte ratios and genetic alterations (e.g., ALK, EGFR) in cancer progression. His recent work explores precision oncology, such as Cyclin-dependent Kinase 9 inhibitors (KB-0742), and health disparities in Hispanic populations with thyroid and lung cancers. His publication record includes clinical trials, case reports, and epidemiological analyses on therapeutic responses (e.g., pembrolizumab, talimogene laherparepvec) and molecular differences between primary and metastatic melanoma. His work bridges bench-to-bedside research, emphasizing real-world treatment outcomes and novel cancer therapies. No scientific awards were explicitly mentioned in the provided text.

• Neuroendocrinology
• Energy Homeostasis
• Obesity Research
• +۵ مورد دیگر

Professor Zane Andrews is a Research Professor in Physiology at Monash University, affiliated with the Monash Biomedicine Discovery Institute (MBDI). He serves as Deputy Head of the Metabolism, Diabetes and Obesity Program at MBDI, Editor-in-Chief for Endocrinology , President of Hypothalamic Neuroscience and Neuroendocrinology Australasia (HNNA), and Council Member of the International Neuroendocrine Federation. Andrews earned his PhD from the University of Otago (2003) and completed postdoctoral training at Yale University (2004-2008). His lab investigates neuroendocrine control of energy homeostasis, focusing on how hunger-sensing systems (e.g., AgRP neurons and ghrelin) regulate food intake, reward, motivation, and cognitive functions. Techniques include optogenetics, chemogenetics, and in vivo calcium imaging. Key research areas include ghrelin’s role in obesity, stress-induced eating behaviors, and neurodegenerative links (e.g., Parkinson’s disease). He leads projects on psychedelic treatments for anorexia, stress-hunger interactions, and brain-sympathetic nervous system interactions in cancer cachexia. Awards include the International Servier Award (2010) and Endocrine Society of Australia Mid-Career Award (2013). Andrews has supervised numerous research projects and is actively mentoring PhD students. His work contributes to UN Sustainable Development Goals addressing health and well-being (SDG 3) and sustainable cities (SDG 11).

• Chronic Kidney Disease
• Bone Health
• Osteoporosis
• +۳ مورد دیگر

Jasna Aleksova is a Research Fellow at the Department of Clinical Sciences, Monash University, affiliated with Monash Health. Her research focuses on bone health, chronic kidney disease, and endocrine disorders, with particular emphasis on fracture prediction, vascular calcification, and osteoporosis mechanisms. She leads projects investigating bone and muscle health in men with chronic kidney disease and improving clinical care for kidney transplant patients. Her work contributes to UN Sustainable Development Goals related to good health and well-being. Key collaborations include projects with Professors Elder, Ebeling, and Milat. She holds the RACP Diabetes Australia Research Establishment Fellowship (2022). Notable research outputs include studies on femoral strength in ovarian insufficiency, cortical hip parameters in kidney disease, and the inverse relationship between aortic calcification and trabecular bone scores in dialysis patients. Her findings advance understanding of comorbid skeletal and vascular pathologies in chronic diseases.

Keith Al-Hasaniمشاهده پروفایل

پژوهشگر ارشد

• Diabetes Research
• Epigenetics
• Pancreatic Regeneration
• +۳ مورد دیگر

Keith Al-Hasani is an Adjunct Senior Research Fellow at Monash University, specializing in diabetes research with a focus on pancreatic regeneration and epigenetic mechanisms. His work contributes to UN Sustainable Development Goals related to health and well-being. Past Affiliations: Vaccine Scientist (Manager), Therapeutic Goods Administration (2016–2017) Research Fellow, INSERM (2009–2012) Research Fellow, Murdoch Children's Research Institute (2001–2004) Research Interests: His research explores epigenetic regulation in β-cell regeneration, diabetic nephropathy biomarkers, and therapeutic targets for diabetes. Key projects include the PanRegen and EpiPR initiatives, investigating pancreatic ductal cell-driven β-cell regeneration and epigenetic modulation. Recent Trends in Publications: Over the past five years, his work emphasizes epigenetic therapies for diabetes complications, pharmacological interventions targeting EZH2, and biomarker discovery for kidney disease susceptibility. Collaborations span Australia, Europe, and Asia. Grants & Projects: Primary Chief Investigator for PanRegen: Pancreas Regeneration Project (2021–2022) Chief Investigator for Epigenetic Pancreas Regeneration (EpiPR) Project (2022) Labs/Teams: Collaborates closely with labs led by S. El-Osta and M. Cooper, focusing on translational research in diabetes and epigenetics.

• Women's Public Health
• Health Services Research
• Reproductive Health
• +۷ مورد دیگر

Associate Professor Jacqueline Boyle is an academic obstetrician/gynaecologist at Monash University's Eastern Health Clinical School, where she leads the Health Systems and Equity Directorate. She holds a clinical appointment at Monash Health and focuses on improving women's health equity across the lifecourse through public health and health services research. Her research priorities include reproductive health optimization, metabolic intersections (e.g., PCOS, menopause, gestational diabetes), and culturally responsive care for migrant/refugee populations. Notable achievements include 6 scientific awards like the Victorian Honour Roll of Women (2015) and Telstra Business Woman finalist (2020). Key projects include co-designing culturally adapted diabetes prevention programs, improving perinatal mental health resources for refugees, and advancing women's health equity through organizational leadership initiatives. Over 277 research outputs emphasize systematic reviews, meta-analyses, and intervention studies addressing global health disparities. Her activities include organizing women's health symposiums in Malaysia and leading workshops on preconception health equity. Current grants total 35 active/funded projects spanning Australia, Nepal, and Asia-Pacific regions.

Jayashri Kulkarniمشاهده پروفایل

استاد

• Women's Mental Health
• Psychoneuroendocrinology
• Schizophrenia
• +۶ مورد دیگر

Professor Jayashri Kulkarni holds dual appointments as Professor of Psychiatry at Monash University and The Alfred Hospital, and directs the Monash Alfred Psychiatry Research Centre (MAPrc). Her leadership expanded MAPrc from 25 to 185 personnel, focusing on translating neuroscience into clinical treatments for severe mental illnesses. She also founded the Australian Consortium for Women’s Mental Health and leads the International Association for Women’s Mental Health. Her research emphasizes women’s mental health, psychoneuroendocrinology (particularly estrogen’s role in psychosis), and trauma’s impact on psychiatric conditions. Education: MBBS from Monash Medical School (1981), PhD in 'Women and Psychosis' (Monash University, 1997), and Fellowship of the Royal Australian and New Zealand College of Psychiatrists (1989). Teaching roles include directing Monash’s undergraduate medical mental health program and coordinating postgraduate psychiatry training. Research interests span hormonal treatments for depression, schizophrenia, and trauma-related disorders. Notable studies include NRAMP (antipsychotics in pregnancy), estrogen’s therapeutic effects, and comorbidities in borderline personality disorder. Her work bridges clinical practice and advocacy, with 110+ clinical trials and 363 publications. Awards include AAHMS Fellowship (2016), multiple editorial recognitions, and innovation awards like the 2010 New Inventors' EVestG diagnostic tool. Collaborations span global networks, addressing autoimmune encephalitis and women’s health initiatives. She leads 72 active research projects and has secured substantial grants/philanthropy. Labs/Teams: MAPrc drives interdisciplinary projects; Monash Alfred Women’s Mental Health Clinic provides specialized clinical care. Future work includes advancing hormonal therapies, early psychosis diagnosis via 'Amber’s Alert,' and improving maternal mental health outcomes.

Harvey Grillمشاهده پروفایل

استاد

• Affective neuroscience
• Behavioral neuroscience
• Energy balance regulation
• +۵ مورد دیگر

Harvey Grill is a Professor and Director of the Obesity Unit at the Institute of Diabetes, Obesity and Metabolism, University of Pennsylvania. His work focuses on neurobiological mechanisms of energy balance, obesity, and metabolic disorders. He holds a BA in Psychology from City College (CUNY), a PhD in Physiological Psychology from NYU, and completed postdoctoral training at Rockefeller University. Research Interests include: Affective neuroscience: food reward, drug reward, and neural systems of feeding motivation Neurophysiology of sensation and perception: taste, gastrointestinal interoception, and vagal afferents Clinical translation: neural control of energy expenditure, obesity drug development, and diabetes treatment Recent work emphasizes distributed neural circuits (hindbrain, hypothalamus, prefrontal cortex) and molecular signaling pathways (GLP-1, leptin, oxytocin) influencing food intake and energy balance. His studies highlight anatomically distributed systems integrating peripheral signals (e.g., ghrelin, vagal afferents) with central motivational processes. Advising includes graduate student Hallie Wald and postdoctoral fellow Tito Borner. Key collaborations involve the Obesity Unit, Perelman School of Medicine, and translational initiatives in pharmaceutical research. His lab actively investigates pharmacological targets for obesity treatment, emphasizing chronic disease management strategies. Labs/Teams: Director of the Obesity Unit, Institute of Diabetes, Obesity and Metabolism, Penn Medicine.

Per Hallمشاهده پروفایل

استاد

• Breast Cancer
• Epidemiology
• Medical Oncology
• +۵ مورد دیگر

Per Hall is a Professor in the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet, with a part-time clinical position at Södersjukhuset. His primary focus is breast cancer prevention and early detection, combining clinical practice with research. He leads the Karma Project, a large-scale cohort study enhancing risk prediction through mammographic features and genetic markers. His work includes developing risk models for personalized screening and evaluating interventions like tamoxifen to reduce breast cancer incidence. Research interests include mammographic density, polygenic risk scoring, and clinical trials assessing drug efficacy (e.g., tamoxifen metabolism). Key projects include SMART (stratified screening trial) and KARISMA (tamoxifen trials). Awards include the 2021 Breast Cancer Association Award for contributions to prevention and early detection. Grants include EU Commission projects, NIH funding, and major Cancer Society grants. Supervised over 20 students, many focusing on breast cancer epidemiology and risk assessment. Collaborates internationally on AI-driven risk models and biomarker research. Active in public outreach through initiatives like Karma Project resources for participants.

Lisa Juntti-Berggrenمشاهده پروفایل

استاد

• Cell and Molecular Biology
• Physiology and Anatomy
• Diabetes Research
• +۳ مورد دیگر

Professor Lisa Juntti-Berggren is a faculty member at Karolinska Institutet's Department of Molecular Medicine and Surgery, specializing in diabetes research with a focus on apolipoprotein CIII (apoCIII). She holds a Docent title from Karolinska Institutet (1997) and has been recognized with the Swedish Society of Medicine's Jubilee Prize (2023) for her contributions to diabetes research. Her work explores how elevated apoCIII levels contribute to diabetes pathogenesis, including β-cell dysfunction, metabolic disorders, and complications like insulin resistance. Key findings include delaying type 1 diabetes onset in mice by lowering apoCIII and identifying its role in obesity-linked insulin resistance. Recent studies (2025-2014) highlight her research on extracellular vesicles, ER stress in β-cells, and therapeutic strategies targeting apoCIII. She collaborates widely, evidenced by co-authored articles and grants from institutions like the Swedish Research Council. Her laboratory is part of the Signal Transduction research group led by Ismael Valladolid-Acebes. Awards include the 2023 Jubilee Prize, acknowledging her discovery of apoCIII's role in diabetes and translational efforts toward drug development. Grants support her exploration of metabolic pathways and apoCIII's diagnostic potential in predicting diabetes complications.

• Autoimmunity and Inflammation
• Immunology
• Cancer Research
• +۴ مورد دیگر

Mikael Karlsson is a Professor at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet. His research focuses on the regulation of the immune system, particularly B cells and macrophages, in autoimmune diseases and cancer. He leads the 'Inflammatory responses in cancer and autoimmunity' research group, which investigates mechanisms underlying autoimmunity, allergy, cardiovascular disease, and tumor microenvironments. Education: Docent (2009), Karolinska Institutet. Active collaborations include institutions such as the University of Toronto, Rockefeller University, and NIH. His group employs advanced techniques like multiphoton microscopy and flow cytometry. Research Interests: Autoimmunity (e.g., systemic lupus erythematosus), cancer immunology, B cell and macrophage interactions, and immunotherapy development. Key projects include targeting TAM macrophages in tumors and studying B cell dysregulation in autoimmune conditions. Publications: Over 100 articles in journals like Cancer Cell , Nature Communications , and Immunity , highlighting work on immune tolerance mechanisms, extracellular vesicle therapies, and cytokine signaling. Lab & Collaborations: Hosts PhD students and collaborates globally. Focus areas include developing novel treatments for autoimmune diseases and cancer through immune modulation.

• Pediatric Endocrinology
• Skeletal Development
• Growth Disorders
• +۴ مورد دیگر

Ola Nilsson is a Professor of Paediatric Endocrinology at the Department of Women’s and Children’s Health, Karolinska Institutet. His research focuses on skeletal development, growth disorders, osteoporosis, and cartilage biology. He leads the Growth and Cartilage Biology research group, aiming to translate cellular and molecular insights into clinical treatments for bone and joint disorders. Education: MD (1998), PhD (2002), and Docent (2011), all from Karolinska Institutet. His work spans over 200 publications, primarily in journals like Journal of Clinical Endocrinology & Metabolism and Orphanet Journal of Rare Diseases . Research interests include genetic and molecular mechanisms regulating growth plate senescence, FGF23 pathways in X-linked hypophosphatemia, and tissue engineering for cartilage regeneration. He collaborates internationally on registries like the XLH Registry and clinical trials for burosumab. Key contributions include defining growth reference charts for achondroplasia and identifying genetic mutations linked to skeletal dysplasias. His lab integrates molecular biology, imaging, and clinical studies to address unmet needs in pediatric endocrinology.

• Cancer and Oncology
• Cell and Molecular Biology
• Bioinformatics and Computational Biology

Galina Selivanova is a **Professor of Cell and Tumor Biology** at **Karolinska Institutet**, Stockholm. She leads the Galina Selivanova Group within the Division of Tumor Biology , focusing on developing small molecules to restore p53 tumor suppression functions. Her work bridges molecular biology, cancer research, and drug development. Education and Career: - **Docent** degree from Karolinska Institutet (2002) - Professor (2010–2025), Senior Professor (2025–present) in the Department of Microbiology, Tumor and Cell Biology. Research Focus: Her pioneering research centers on the p53 protein , a key tumor suppressor. Projects include: - Pharmacological reactivation of mutant p53 and its role in cancer immune escape. - Design of small molecules like APR-246/APR-246 and RITA analogs targeting oncogenic pathways. - Exploring synergistic therapies combining p53 reactivation with immunotherapy or chemotherapy. Grants: - Swedish Research Council (e.g., 2020–2023 grant targeting p53-driven immune responses). - Swedish Cancer Society (multiple grants since 2015 for p53-based cancer therapy research). - Wallenberg Foundation (2013–2018) for pro-senescence therapy in melanoma. Lab and Collaborations: Her group collaborates internationally to advance translational oncology , emphasizing drug design, molecular mechanisms, and clinical relevance. Key projects involve thermal proteome profiling, network biology, and preclinical drug testing.

• Cancer Research
• Pharmacology
• Medical Sciences
• +۳ مورد دیگر

Deborah Fischer holds the position of Researcher in Pharmacy, contributing to medical research with a focus on pharmacology, cancer biology, and endocrine disorders. Her work aligns with UN Sustainable Development Goals through advancements in healthcare innovation. She is affiliated with the Christabel Pankhurst Institute under the Advanced Materials in Medicine research platform. Department: Pharmacy Key Research Areas: Endometrial Cancer, Cancer Stem Cells, Prostaglandin Receptors, Mouse Model Development Her research explores topics such as regulatory T cell modulation, fibroblast growth factor inhibitors for endometriosis, and metformin's role in cancer stem cell activity. Fischer has published extensively in journals like Biochemical Pharmacology and Pharmacology research & perspectives , with notable work on omega-3 fatty acids' immune effects and prostaglandin receptor functions in human reproduction. Her studies often utilize mouse models to bridge preclinical and translational research. Fischer's research has garnered significant attention, including 52 social media shares and 40 Mendeley readers for her 2022 study on ceramide pathways. She has supervised 1 student project and collaborates with experts in pharmacology, oncology, and reproductive biology.